Blood 101. Dr. Karen L. Dallas. Medical Director, Hematopathology & Transfusion Medicine Providence Health Care

Similar documents
Improving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm

Coagulation Mechanisms Dr. Nervana Bayoumy

Introduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO

Coagulation in perspective: Blood management. Objectives

Disclosures. Thromboelastography. TEG Methodology. TEG Output. Thromboelastography (TEG): Basics & Clinical Applications

These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.

Hematology Emergencies: Problems with Platelets

Physiology Unit 3 HEMATOLOGY

Sign up to receive ATOTW weekly -

Ch 13: Blood. What does blood do? Transport: Regulation: Protection:

LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY

Laboratory investigation in the Bleeding Patient. Dr Craig Taylor Consultant Haematologist May 2016

BLOOD COAGULATION. 1. The initial phase of the process is vascular constriction. This limits the flow of blood to the area of injury.

The Coagulation Workup In The Office Setting

Innovations with "Best of Breed" Solutions:

Haemostasis. The function of haemostasis is: to prevent blood loss from injured vessels. to stop bleeding. to prevent thrombosis

*NCCT is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program, provider #122.

ROTEM Basic Interpretation Guide

Evaluation of Complex Coagulation Cases: Case-Based Illustrations of Important Issues

Special Coagulation - APC Resistance. DiaPharma Group, Inc. Customer Service: Technical Support:

Common Inherited Bleeding Disorders

The Story of the Platelet Clump. Wayne Hall MTN Network Laboratory Magee-Womens Research Institute Pittsburgh, PA

Massive Haemorrhage J Davies B Ferguson

Pharmacotherapy Resuscitation in Acute Traumatic Coagulopathy: Ready for Prime Time? September 29, 2017

Category Storage Shelf Life Additional Criteria

Upon completion of the Clinical Hematology rotation, the MLS student will be able to:

Blood Product Utilization

Methods of Biomaterials Testing. Special Biology: Blood & Vessel

Common Inherited Coagulation Disorders. Inherited Coagulation Disorders. All coagulation factors and platelets in circulation (unactivated)

DEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK

Basic coagulation applications and case studies

Dr Kate Talks, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Trust Nov 2012

Overview of Anatomy and Physioloy II Second Year Students

Aligning Lab Goals & Institutional Goals Laughlin Rice

Rheological and biochemical analyses on blood coagulation ~ Discovery of a new pathway under stagnant flow conditions ~

Hematotoxin producing snakes in Thailand พญ.ม ชฌ มา รอดเช อ พญ.อ สร ย หาญอ ท ยร ศม

EDUCATIONAL COMMENTARY D-DIMER UPDATE

Smouldering myeloma. Myeloma Infosheet Series. Other related conditions. Infoline:

Red Cell Transfusion LESSONS FROM TRAUMA

CHANGE IN PLATELET USAGE

Coagulation: The Ins and Outs. Sheila K. Coffman BSMT (ASCP)

Clinical laboratory costing

Veins Valves prevent engorgement and backflow. Baroreceptor reflex. Veins returning blood

Registry for haemophiliacs in France : FranceCoag Network. Thierry Lambert, MD

The Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2

Celluvative. Cellular Therapies Redefined. A portfolio of products and services brought to you by: Saving lives today. Improving life tomorrow.

Table of Contents. Introduction. Worldwide Market and Technology Overview

The evolution of TQIP Best Practices for Massive Transfusion

Aligning Process Redesign and Change Management with Project Management (System Implementation Projects)

Session 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy

Chapter 19b Blood, cont d

Profibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders

COAGULATION: BASIC PRINCIPLES. Peyman Eshghi Prof. of Pediatric Hematology & Oncology

Laboratory Investigation of Challenging Cases. Laura A. Worfolk, Ph.D Scientific Director, Coagulation

Implementation of massive transfusion protocols to guide practice in severe bleeding- is your institution ready?

Information and resources for African Americans living with multiple myeloma and their caregivers

BUSINESS UPDATE CALL. September 7, 2017

The Power in You. TM

CLOTTING FACTORS AND COAGULANT BLOOD PRODUCTS

Blood is 55% Plasma (Liquid)

Dr. Suzana Voiculescu

LVHN Scholarly Works. Lehigh Valley Health Network. Joseph G. Ottinger RPh, MS, MBA, BCPS Lehigh Valley Health Network,

2 Thomas G. DeLoughery

ROTEM/TEG. Circulation in trauma: From roadside to bedside. A/Prof David Roxby SA Pathology Transfusion Service South Australia

Coagulation Laboratory: Methods, Standards & Cost Effective Testing Part 1

OERMATAN SULFATE: A NEW CONCEPT IN ANTITHROMBOTIC THERAPY

Coding Essentials for Laboratories 2017

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

The Tri-F Titer. Fibrinolysis, Fibrin(ogen) Split Products, and Heparin. Cary J. Lambert, M.D., Alain J. Marengo-Rowe, M.D.,

Use of Thromboelastography in the Management of the Trauma Patient Rio Grande Trauma Conference

Serine Proteases and their Inhibitors

Update on the IVDR. Sue Spencer

Auditing The Preanalytical Phase: Lessons from 40+ Audits

UPDATE ON SPECIFIC ANTIDOTES FOR TARGET-SPECIFIC ORAL ANTICOAGULANTS

Wolf EMR. New Product Features and Roadmap Update. Rowan Helmer, Sr. Product Manager. Western EMR User Conference 2016

Note: The taller 100 x 13 mm tube is not designed to run on the ACL TOP. Plasma after centrifugation of these tubes must be placed in sample cups.

Clinical Policy: Eculizumab (Soliris) Reference Number: ERX.SPMN.225

MEDICAL LABORATORY SCIENCES (MLSC)

A MANUFACTURING PROCESS TO OBTAIN A HIGHLY-PURIFIED TRIPLE-SECURED FIBRINOGEN PRODUCT

Laboratory: Document Type: Original Date Adopted: Previous Document: Transfusion Services Procedure 04/01/02 TRB-9 Revision 4

Software Regulation: The Transfusion Medicine Experience

Clinical Policy: Humate-P (Antihemophiliac Factor/von Willebrand Factor Complex Human) Reference Number: CP.MP.404

Therapeutic monoclonal antibodies & blood transfusion Essential information for hospital transfusion laboratories, transfusion practitioners &

THE SCIENCE OF PLATELET RICH PLASMA

Preanalytical Variables in Blood Collection: Impact on Precision Medicine

Regulation of Absorbable Hemostatic Agents: Guidance for. Encouraging Innovation Without Compromising Patient Safety

ASSAY METHODS FOR THE EXPLORATION OF FIBRINOLYSIS

Marcia L. Zucker, Ph.D. ZIVD LLC

Spanish Paediatric Clinical Trials Network (RECLIP)

Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase

FACTOR XIII DEFICIENCY IN PAKISTAN

BEYOND A BETTER BOX DI-60 INTEGRATED SLIDE PROCESSING SYSTEM. Seamless Integration

Guidelines for the use of blood warming devices(aabb) Reference: 2002 AABB

Apheresis Anticoagulant Removal. Oluwatoyosi Onwuemene, MD MS May 6th, 2017

Transcription:

Blood 101 Dr. Karen L. Dallas Medical Director, Hematopathology & Transfusion Medicine Providence Health Care

Alternate Title?: Inside Knowledge About How We re Helping You in the Hematology Laboratory

Overview & Objectives Get to know more about the inner workings of a Blood Lab this is where are the nuts & bolts of diagnosis actually happens! Hematology Blood Bone Marrow Coagulation Transfusion Medicine Explore how we can ALL work better together for improved patient care

About me (I m a Nomad!) American originally (don t hold it against me!) University of Minnesota Bachelor s in Microbiology & French NIH Postbaccalaureate Research Fellowship McGill Medical School Electives in Halifax, Ottawa, Edmonton, West Africa University of Toronto Hematopathology Residency Electives in NYC, Cleveland Clinic, Vancouver, West Africa Health Services Management Certificate (Toronto) BloodCenter of Wisconsin TM/Coag Fellowship Elective in East Africa Saskatoon & Northern SK Edmonton Vancouver & Yukon Territories

In Vancouver St. Paul s Hospital City-wide on-call Consultant to Yukon Terr. UBC Clinical Associate Prof, TM Program Director TMAG (Transfusion Medicine Advisory Group) Physician Engagement Committee UBC Physician Leadership Program Regional Physician-Led QI Steering Committee MSA Executive

Doctor/Personal Trainer/ Physique Competitor

Putting Quality into Perspective

Patient Blood Management Current Hot Topic Fine line in TM Ultimate Goal: Right product to the right patient at right time and for right reason!

Blood is not FREE! RBC $422 /unit Platelets $185-485 /dose Plasma $100-375 /unit afvii $1200 /1 mg Transfusion April 2010. Vol 50(4), 753-765.

Blood is also not without RISK Serious Hazards Of Transfusion = SHOT Confidential Survey of UK and Irish hospitals, 10/96 to 9/98 (and ongoing ) Deaths and Major complications of Transfusion 65% participation 191 (52%) wrong blood to patient 3 deaths due to ABO incompatibility

SHOT Continued

Transfusion Safety Lab/Blood Bank errors alone: 29% Non-blood bank errors alone: 56% Combination of errors: 15% Failure to identify the patient is the major error found during investigation Linden, JV. Transfusion errors in New York State: an analysis of 10 years experience. Transfusion 2000; 40:1207-1213.

But what IS transfusion safety? The promotion of patient safety during the blood transfusion process: sample collection sample testing ordering of transfusion administration post-transfusion assessment Goal: Getting the right blood product to the right patient at the right time and for the right reason!

Deaths reported to the FDA (2005-2010) Transfusion still kills!

Who is involved in transfusion safety? Physician/Medical Phlebotomy Transfusion service (Blood Center & Blood Bank) Nursing Patient/Family

Launched in 2012 by the ABIM Foundation Goal of advancing a national dialogue on avoiding wasteful or unnecessary medical tests, treatments & procedures More than 70 specialty societies have joined in with their recommendations Choosing Wisely Canada!

http://www.choosingwiselycanada.org/ Cool lists Cool videos Cool patient materials Cool APP

Hemostatic Process Endothelium damaged Change in Area of Injury Endothelial Cells Platelet Shape Collagen ADP AA Platelet Platelet plug formed (white clot) Thrombin generated on platelet surface XII XIIa XI XIa IX V V X + Ca 2+ VIIa /TF VII Coagulation Cascade Pr ombin (II) Thr XIII XIIIa Platelet-fibrin plug formed (red clot) tpa Plasminogen Plasmin Fibrin Strands Degradation Products Fibrinolysis Clot lysis

Routine Coagulation Tests Based on cascade model of coagulation Measure protein interaction in plasma (thromboplastin) Exclude cellular contributions (platelets, monocytes, etc.) Determine adequacy of coagulation factor levels Use static endpoints Ignore altered thrombin generation Ignore cellular elements Ignore overall clot structure

Whole blood test TEG / ROTEM Measures hemostasis Clot initiation through clot lysis Net effect of components TEG/Rotem system Laboratory based Point of care Remote, can be networked Flexible to institution needs

Thromboelastography (TEG)

Informational E-survey n = 30 ER Docs ICU Docs GIM Docs Results: 73% Do not typically order PBF s 47% Did not know Lab auto-generates PBF s 67% Have received a PBF report when not ordered 7% Unaware Majority felt we could improve!*

Our Stepwise Change Implementation 73/mo 110/mo Dec 2015 118/mo Aug 2016 112/mo Oct 2016 136/mo Jan 2016 111/mo Sep 2016 88/mo Nov 2016 July 2015 Feb 2017 44/mo Dr. Dallas starts at SPH Opportunity Identified Physician Informational Survey Abnormal CBC Flag ++ Ongoing Education

#2: BM Biopsy Drill ARROW OnControl

Reported Benefits: Better specimen quality Higher patient satisfaction Less pain during and 24 hours later Less need for repeat procedures Time saving Reported 55% faster procedure time!

Questions? E-mail: KDallas@ProvidenceHealth.bc.ca Phone: (604) 806-9355 (office) (604) 230-3182 (cell/text)**